MedPath

The effectiveness of Cerclage for the reduction of extreme preterm birth and perinatal mortality in Twin pregnancies with a short cervix.

Recruiting
Conditions
10010273
Premature birth
Preterm birth
preterm deliveru
Registration Number
NL-OMON53843
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
200
Inclusion Criteria

Women above the age of 16 years with a twin pregnancy and an asymptomatic short
cervix or dilatation at routine ultrasound investigation below 24 weeks of
pregnancy

Exclusion Criteria

- Women with a mono-amniotic twin pregnancy
- Women with twin pregnancy in which one or both children are diagnosed with a
major structural, congenital or chromosomal abnormality that is likely to
influence the composite adverse neonatal outcome.
- Women with dilatation of the cervix and signs of clinical intra-uterine
infection, defined by the presence of fever >= 38 degrees Celsius.
- Women with overt symptoms of preterm labour at time of measurement of short
cervix (regular contractions, PPROM, recurrent blood loss).
- Women with a placenta previa, defined as a placenta position covering the
internal ostium of the cervix.
- Women who do not master the Dutch of English language and therefore not able
to give written consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary outcome will be extreme PTB < 28 weeks.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary outcomes include a composite for adverse neonatal outcome, PTB < 24,<br /><br>32 and 34 weeks,GA at delivery, PPROM, days on ventilation support, in NICU,<br /><br>maternal quality of life and maternal outcomes, and societal costs. Outcome<br /><br>measures are in line with the core outcome sets for evaluation of interventions<br /><br>to prevent PTB.</p><br>
© Copyright 2025. All Rights Reserved by MedPath